TruSpine Technologies Plc

Declaration of Voting Results & Voting Rights Announcements • Apr 7, 2025

National Storage Mechanism | Additional information

RNS Number : 8315D

TruSpine Technologies PLC

07 April 2025

7 April 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

Webinar

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce a live Webinar hosted by Geoff Miller, CEO of the Company, via the Company's recently updated Investor website on Friday, 11 April 2025, at 10:00 AM BST.

This session is open to all existing and prospective shareholders.

Questions can be submitted in advance via the webinar page until Wednesday, 9 April 2025 at 10:00 AM BST, or asked live during the event.

Register for free here at the link below.

https://truspinetech.com/webinars/Ve95oe-2024-agm-webinar?roomCode=icn-ikdk-gve

The Directors of the Company are responsible for the release of this announcement.

-END-

TruSpine Investor Hub	https://investorhub.truspinetech.com
TruSpine Technologies Plc	Tel: +44 (0)20 7118 0852
Geoff Miller, Non-executive Chairman
Peterhouse Capital Limited (Broker & Financial Adviser)	Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Novus Communications (PR and IR)	Tel: +44 (0)1273 704 473
Alan Green / Jacqueline Briscoe	[email protected]

This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRABLGDSDUGDGUL